Company News for October 27, 2022

  • Shares of Moderna, Inc. MRNA rose 4% after reports emerged that it was close to reaching a deal with the US government to develop vaccines against Ebola and other biological threats.
  • V shares of Visa Inc. gained 4.6% after the company reported earnings of $1.93 per share in the fourth quarter of fiscal 2022, beating Zacks consensus estimate of $1.86 per share.
  • Shares of Canadian National Railway Company CNI rose 3.4% after the company reported earnings of $1.63 per share in the third quarter of 2022, beating the Zacks consensus estimate of 1 $.51 per share.
  • The Boeing Company’s BA shares plunged 8.8% after reporting third-quarter 2022 revenue of $15.96 billion, significantly missing Zacks’ consensus estimate of $17.50 billion.

This Little-Known Semiconductor Stock Could Be Your Portfolio’s Inflation Hedge

Everyone uses semiconductors. But only a small number of people know what they are and what they do. If you use a smartphone, computer, microwave, digital camera, or refrigerator (and that’s just the tip of the iceberg), you need semiconductors. This is why their importance cannot be overstated and their disruption in the supply chain has such a global effect. But every cloud has a silver lining. The shockwaves on the international supply chain from the global pandemic have exposed a tremendous opportunity for investors. And today, Zacks’ top stock strategist reveals the single semiconductor stock with the most to gain in a new FREE report. It’s yours at no cost and without obligation.

>>Yes, I want to help protect my portfolio during the recession

Want the latest recommendations from Zacks Investment Research? Today you can download 7 best stocks for the next 30 days. Click to get this free report

The Boeing Company (BA): Free Inventory Analysis Report

Visa Inc. (V): Free Stock Analysis Report

Canadian National Railway Company (CNI): Free Inventory Analysis Report

Moderna, Inc. (MRNA): Free Stock Analysis Report

To read this article on, click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Karen J. Nelson